Enbrel Enables Immunex To Shine In 1998; Stock Gains 133%
Executive Summary
The launch of Enbrel is helping Immunex to move firmly into the top-tier of biotechnology companies - and may help to reinvigorate investor enthusiasm for biotech research overall.